Craig Rosenstein

437 total citations
9 papers, 283 citations indexed

About

Craig Rosenstein is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Craig Rosenstein has authored 9 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Craig Rosenstein's work include Cytokine Signaling Pathways and Interactions (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Craig Rosenstein is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Craig Rosenstein collaborates with scholars based in United States. Craig Rosenstein's co-authors include Samuel Younkin, Terrone L. Rosenberry, Peter L. Collins, Christopher J. Dinsmore, Jonathan R. Young, Grace Chan, Lin Xu, Michael D. Altman, C. Gary Marshall and Hong Yin and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Craig Rosenstein

9 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Rosenstein United States 7 133 110 63 62 56 9 283
Zejin Sun United States 8 112 0.8× 227 2.1× 14 0.2× 64 1.0× 18 0.3× 19 450
Christine Harman United States 8 63 0.5× 146 1.3× 45 0.7× 17 0.3× 18 0.3× 8 346
Nicolò Tonali France 12 49 0.4× 238 2.2× 61 1.0× 41 0.7× 8 0.1× 31 375
Thierry Taverne France 7 133 1.0× 165 1.5× 164 2.6× 28 0.5× 6 0.1× 9 379
L Rondahl Sweden 6 62 0.5× 225 2.0× 79 1.3× 28 0.5× 16 0.3× 8 377
Masami Shiratsuchi Japan 9 50 0.4× 182 1.7× 78 1.2× 14 0.2× 8 0.1× 20 345
Damien Hédou France 10 172 1.3× 153 1.4× 224 3.6× 116 1.9× 4 0.1× 15 466
Payam Baziyar Iran 11 55 0.4× 105 1.0× 15 0.2× 22 0.4× 10 0.2× 24 331
Scott C. Mayer United States 12 63 0.5× 271 2.5× 177 2.8× 24 0.4× 7 0.1× 25 461
Manish Malviya India 11 48 0.4× 87 0.8× 48 0.8× 27 0.4× 4 0.1× 17 301

Countries citing papers authored by Craig Rosenstein

Since Specialization
Citations

This map shows the geographic impact of Craig Rosenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Rosenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Rosenstein more than expected).

Fields of papers citing papers by Craig Rosenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Rosenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Rosenstein. The network helps show where Craig Rosenstein may publish in the future.

Co-authorship network of co-authors of Craig Rosenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Rosenstein. A scholar is included among the top collaborators of Craig Rosenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Rosenstein. Craig Rosenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Haidle, Andrew M., Craig Rosenstein, Michael D. Altman, et al.. (2014). Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms. Bioorganic & Medicinal Chemistry Letters. 24(8). 1968–1973. 9 indexed citations
2.
Siu, Tony, Michael D. Altman, Matthew H. Katcher, et al.. (2014). The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 24(6). 1466–1471. 6 indexed citations
3.
Lim, Jongwon, Ryan D. Otte, Kerrie B. Spencer, et al.. (2011). Discovery of 1-Amino-5H-pyrido[4,3-b]indol-4-carboxamide Inhibitors of Janus Kinase 2 (JAK2) for the Treatment of Myeloproliferative Disorders. Journal of Medicinal Chemistry. 54(20). 7334–7349. 59 indexed citations
4.
Siu, Tony, Joon Jung, Craig Rosenstein, et al.. (2010). The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead. Bioorganic & Medicinal Chemistry Letters. 20(24). 7421–7425. 22 indexed citations
5.
Rosenstein, Craig, et al.. (2007). Quality Control Procedures for Dose-Response Curve Generation Using Nanoliter Dispense Technologies. SLAS DISCOVERY. 12(6). 891–899. 15 indexed citations
6.
Selman, Warren R., et al.. (1994). Temporary vessel occlusion in spontaneously hypertensive and normotensive rats. Journal of neurosurgery. 80(6). 1085–1090. 18 indexed citations
7.
Selman, Warren R., R. Christian Crumrine, Craig Rosenstein, et al.. (1991). Rapid metabolic failure in spontaneously hypertensive rats after middle cerebral artery ligation. Metabolic Brain Disease. 6(2). 57–64. 2 indexed citations
8.
Younkin, Samuel, Craig Rosenstein, Peter L. Collins, & Terrone L. Rosenberry. (1982). Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm.. Journal of Biological Chemistry. 257(22). 13630–13637. 149 indexed citations
9.
Younkin, Steven G., et al.. (1982). Partial purification by vacuum distillation of a factor that increases the junctional acetylcholinesterase of organ cultured rat diaphragm. Brain Research. 249(1). 192–194. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zejin Sun Breakdown of academic impact, for papers by Christine Harman Breakdown of academic impact, for papers by Nicolò Tonali Breakdown of academic impact, for papers by Thierry Taverne Breakdown of academic impact, for papers by L Rondahl Breakdown of academic impact, for papers by Masami Shiratsuchi Breakdown of academic impact, for papers by Damien Hédou Breakdown of academic impact, for papers by Payam Baziyar Breakdown of academic impact, for papers by Scott C. Mayer Breakdown of academic impact, for papers by Manish Malviya
Rankless by CCL
2026